Home ›
Trademark Categories ›
Pharmaceuticals ›
2021 ›
RY ›
RYBIRTRA
Trademark search for:
RYBIRTRA
No active United States Patent and Trademark Office (USPTO) registrations found, based on publicly available USPTO trademark records.
Trademark records may change over time.
For the most up-to-date trademark status, domain availability,
and social handle checks, run a live search.
Check latest trademark, domains & social handles
Live search · Most up-to-date results
USPTO Filing History
Key events recorded for this trademark application
2021-06-08 — Application filed
2021-06-11 — Application filed
2021-08-28 — Application filed
2022-02-25 — Assigned to examiner
2022-03-07 — Approved for pub - principal register
2022-03-23 — Notification of notice of publication e-mailed
2022-04-12 — Published for opposition
2022-04-12 — Official gazette publication confirmation e-mailed
2022-05-06 — Extension of time to oppose received
2022-07-29 — Teas post publication amendment received
2022-08-15 — Assigned to petition staff
2022-08-16 — Post publication amendment - entered
2022-08-21 — Extension of time to oppose process - terminated
2022-10-04 — Noa e-mailed - sou required from applicant
2023-03-10 — Sou teas extension received
2023-03-10 — Sou extension 1 filed
2023-03-10 — Sou extension 1 granted
2023-03-14 — Notice of approval of extension request e-mailed
2023-09-06 — Sou teas extension received
2023-09-06 — Sou extension 2 filed
2023-09-06 — Sou extension 2 granted
2023-09-08 — Notice of approval of extension request e-mailed
2024-03-04 — Sou extension 3 filed
2024-03-04 — Sou teas extension received
2024-03-04 — Sou extension 3 granted
2024-03-05 — Notice of approval of extension request e-mailed
2024-04-11 — Teas change of correspondence received
2024-04-11 — Attorney/dom.rep.revoked and/or appointed
2024-04-11 — Teas revoke/app/change addr of atty/dom rep received
2024-05-24 — Teas change of correspondence received
2024-05-24 — Teas revoke/app/change addr of atty/dom rep received
2024-05-24 — Attorney/dom.rep.revoked and/or appointed
2024-09-11 — Notice of approval of extension request e-mailed
2024-09-11 — Sou teas extension received
2024-09-11 — Sou extension 4 granted
2024-09-11 — Sou extension 4 filed
2025-10-14 — Application abandoned
2025-10-14 — Application abandoned
2025-10-14 — Final status recorded
Owner Information
Alexion Pharmaceuticals, Inc.
Boston , MA
Alexion Pharmaceuticals, Inc.
Boston , MA
Correspondent
Cara M. Kearney AstraZeneca Pharmaceuticals LP 1800 Concord Pike, A2C Wilmington, DE 19850-5437 United States
Filing Details
Filing Date:
2021-06-08
Status Date:
2025-10-14
Disclaimer: This page is informational only and does not constitute legal advice.
Trademark availability depends on jurisdiction, usage, and legal interpretation.